Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. - Wikidata - awgldk - TriplyDB

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

http://www.wikidata.org/entity/Q44001857

about

PPARs and the cardiovascular system Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease Revealing a steroid receptor ligand as a unique PPARγ agonist Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1 Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-γ in CD36 Protein Expression and Foam Cell Formation Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids.The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection.The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.Aiming drug discovery at lysophosphatidic acid targets.Low-dose alcohol consumption protects against transient focal cerebral ischemia in mice: possible role of PPARγ.Identification of UV-protective activators of nuclear factor erythroid-derived 2-related factor 2 (Nrf2) by combining a chemical library screen with computer-based virtual screening.β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.Effect of PPARγ inhibition during pregnancy on posterior cerebral artery function and structure Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.Modulation of adipocyte lipogenesis by octanoate: involvement of reactive oxygen species.PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism.Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells.A subclass of acylated anti-inflammatory mediators usurp Toll-like receptor 2 to inhibit neutrophil recruitment through peroxisome proliferator-activated receptor gamma Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages

P2860

Q24642728-0D59B25B-C8EF-4305-A225-053E9DA904C3 Q24655111-0776E2CE-42BC-4B5F-A353-2161BCE4837B Q26851490-1FC699F6-4290-4E0E-8290-40E740D666CE Q27674914-B8539A01-B285-47CC-9743-EC5393624E1B Q27683508-EEB00BEA-6E44-4647-96E6-F34A459371A7 Q27865233-4C254F44-4854-4291-9FB7-70462927E03E Q28115789-D53C8411-14C1-4A02-973A-C9683684BE4C Q28283135-FFEB6C0C-FF35-40CE-AFE3-99B3427C7ADA Q28513582-3303E241-6A21-475F-BC9E-3401BDA8ECFC Q28533399-D01D467B-542F-461B-A5C9-A8A52922B532 Q30374785-82D5A41D-F42E-4837-B173-7BDE4922994B Q30422017-A0AD0B9F-3367-4C15-8DFD-AED7FD702536 Q30486738-9369DEDC-713A-4F3D-A6CC-9AE302507878 Q30538666-A7604314-6166-44B6-91B6-8CABCFA40C81 Q33196298-4ACF516E-3BFB-4A53-9DF2-494B2F19089E Q33236495-6D46B443-57F8-476C-AAA1-4F8E5300003D Q33380951-E4B3B7F0-9CA1-42A0-B75E-68B05C409E3C Q33496190-6DCA9D76-7CE1-4FC4-B7DB-9FE19D9B4B5A Q33514867-1A683BB1-D494-4887-90E6-A337D0006B74 Q33641441-588D5E42-151A-429D-990F-037944C1A466 Q33865064-DF23BE23-CCFE-46A5-8665-8B6C8197E88F Q34287296-87CF28F1-F4EA-4A83-8B8D-87D69C2D6AB1 Q34330155-C8E46C41-F136-4522-8787-58D9D8EA33DB Q34339759-5FC8D333-84B3-4206-BC22-E4D4466732D7 Q34358879-0CEFD793-F1EC-45B1-8A86-D3BD038772EB Q34360715-B5AC44E2-5F2D-423C-BA7F-E6785E9E0F76 Q34525599-4CBC1FBF-4F06-4B30-AC01-9A11F8D369E8 Q34691864-D2464BF3-4F4D-42AD-9922-4CF83A0162FD Q34751984-3A59B143-03F5-4AE6-ACC6-185DEB23D897 Q34997620-52FC2114-B121-45B7-89E3-0E788284E54C Q35046094-A53E7EB9-4461-4C7E-92D8-4D98DA694F21 Q35085272-F6356E6D-932E-41AE-896C-60728F4BB69E Q35101448-7FE21669-63B0-4502-88F4-3D6AF5FA5D81 Q35101512-3913FAE9-D24E-4C0D-A87C-510C4E9271C9 Q35125945-142D7492-9B41-4095-8865-5EE221AC55F3 Q35132162-26A57402-90FC-4995-817B-8AEF01950744 Q35187029-685E921D-E141-4BBE-ADCD-A32BEBA75FB4 Q35223008-72575A0E-EEB8-4BA5-AF24-70FFAAC155CF Q35239802-41D1E005-B9E7-419E-A167-FC3BBE0C623E Q35355559-1D9A7A1C-3B94-43AB-8F58-591D3BBF7F57

P2860

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

http://www.wikidata.org/entity/Q44001857

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Functional consequences of cys ...... activated receptors by GW9662.

@en

Functional consequences of cys ...... activated receptors by GW9662.

@nl

type

label

Functional consequences of cys ...... activated receptors by GW9662.

@en

Functional consequences of cys ...... activated receptors by GW9662.

@nl

prefLabel

Functional consequences of cys ...... activated receptors by GW9662.

@en

Functional consequences of cys ...... activated receptors by GW9662.

@nl

P1433

Q44001857-1FC27437-A89C-43B7-B001-F54BE633CB1E

P1476

Q44001857-EBE865E4-1683-4CCC-87B6-C8B0EFF8389E

P2093

Q44001857-0F4858B1-E2F7-4546-8AE0-DFEF2E46BCC9

Q44001857-112A52BE-1E9E-41FA-9980-658ECAE06736

Q44001857-1F4A41AB-A20D-410F-B2A7-724B55CCA1D2

Q44001857-214176FC-E74C-4903-B9FB-77A0ACF38F35

Q44001857-348645BF-979E-4CE7-802A-4901673CD1A6

Q44001857-3819FE0B-DFAE-4C24-8115-C0707B144BA9

Q44001857-61854213-D728-4973-9F8D-CCABF9056453

Q44001857-9C847A3A-B92F-4594-A13E-1DB6FC47E3EC

Q44001857-C6AA0A70-1A7A-419B-83FD-9E7A70395513

Q44001857-C6AF3FA0-7071-4649-A124-41657E9F5648

P304

Q44001857-BBA572C8-B1E5-4D05-BFD6-47A68DA9DD42

P31

Q44001857-A5AF9972-636B-4F05-9108-4EC92E5BCBD0

P356

Q44001857-818C03B6-50C5-4A1A-ABCA-402AC3750C11

P407

Q44001857-A9FB3DB3-D74E-4AB2-B2BD-9582698BBCD3

P433

Q44001857-BAEF70E4-B5ED-4631-B278-9564BBE56237

P478

Q44001857-2A94712D-6FE9-4E18-9BB0-5B6DFD38BC4F

P577

Q44001857-C8787248-58EF-4D11-915D-FCE4C3D6790E

P698

Q44001857-C8FAAA8A-30AB-46D4-8D88-96B987324D6C

P921

Q44001857-D4132350-DB69-4777-B02D-E27AC77A5A0E

P356

P1433

P1476

Functional consequences of cys ...... activated receptors by GW9662.

@en

P2093

Christina Therapontos

http://www.w3.org/2001/XMLSchema#string

Derek J Parks

http://www.w3.org/2001/XMLSchema#string

Emily A Hull-Ryde

http://www.w3.org/2001/XMLSchema#string

James M Lenhard

http://www.w3.org/2001/XMLSchema#string

Jeff E Cobb

http://www.w3.org/2001/XMLSchema#string

Jennifer L Shenk

http://www.w3.org/2001/XMLSchema#string

Jon L Collins

http://www.w3.org/2001/XMLSchema#string

Julie B Stimmel

http://www.w3.org/2001/XMLSchema#string

Kelli D Plunket

http://www.w3.org/2001/XMLSchema#string

Lisa M Leesnitzer

http://www.w3.org/2001/XMLSchema#string

P304

6640-6650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BI0159581

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12022867

http://www.w3.org/2001/XMLSchema#string

P921